These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

189 related articles for article (PubMed ID: 17698234)

  • 41. Expression, purification and characterization of recombinant human interleukin-2-serum albumin (rhIL-2-HSA) fusion protein in Pichia pastoris.
    Lei J; Guan B; Li B; Duan Z; Chen Y; Li H; Jin J
    Protein Expr Purif; 2012 Jul; 84(1):154-60. PubMed ID: 22609631
    [TBL] [Abstract][Full Text] [Related]  

  • 42. [An experimental study on antiviral effects of IFN alpha].
    Lu NF; Huang AL; Tang N; Zheng RQ; Lin H; Zhu YB; Wu Y; Tao P
    Zhonghua Gan Zang Bing Za Zhi; 2005 Dec; 13(12):892-6. PubMed ID: 16381632
    [TBL] [Abstract][Full Text] [Related]  

  • 43. [Production of purified human recombinant alpha2b-interferon].
    Mel'nik AI; Orlovskaia IV; Zholobak NM; Spivak NIa
    Mikrobiol Z; 2012; 74(3):72-8. PubMed ID: 22830200
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Preparation and characterization of a novel exendin-4 human serum albumin fusion protein expressed in Pichia pastoris.
    Huang YS; Chen Z; Chen YQ; Ma GC; Shan JF; Liu W; Zhou LF
    J Pept Sci; 2008 May; 14(5):588-95. PubMed ID: 17994612
    [TBL] [Abstract][Full Text] [Related]  

  • 45. A Highly Bioactive Lys-Deficient IFN Leads to a Site-Specific Di-PEGylated IFN with Equivalent Bioactivity to That of Unmodified IFN-α2b.
    Imada T; Moriya K; Uchiyama M; Inukai N; Hitotsuyanagi M; Masuda A; Suzuki T; Ayukawa S; Tagawa YI; Dohmae N; Kohara M; Yamamura M; Kiga D
    ACS Synth Biol; 2018 Nov; 7(11):2537-2546. PubMed ID: 30277749
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Lymphoblastoid interferon alfa-n1 improves the long-term response to a 6-month course of treatment in chronic hepatitis C compared with recombinant interferon alfa-2b: results of an international randomized controlled trial. Clinical Advisory Group for the Hepatitis C Comparative Study.
    Farrell GC; Bacon BR; Goldin RD
    Hepatology; 1998 Apr; 27(4):1121-7. PubMed ID: 9537453
    [TBL] [Abstract][Full Text] [Related]  

  • 47. RSM optimization of HSA/IL1Ra in Pichia pastoris overexpression strain and study of its in vivo activity in reducing hyperglycemia of GK rats.
    Liu W; Zhao W; Lai J; Shen Q; Xu Y; Pan L; Chen S
    Biotechnol Appl Biochem; 2017 Sep; 64(5):627-637. PubMed ID: 27572239
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Antiproliferative properties of chemically modified recombinant IFN-alpha2b.
    Martynov AV; Smelyanskaya MV
    J Interferon Cytokine Res; 2005 Jul; 25(7):414-7. PubMed ID: 16022586
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Development and characterization of a novel fusion protein of a mutated granulocyte colony-stimulating factor and human serum albumin in Pichia pastoris.
    Huang YS; Wen XF; Yang ZY; Wu YL; Lu Y; Zhou LF
    PLoS One; 2014; 9(12):e115840. PubMed ID: 25535738
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Creation of interferon-alpha8 mutants with amino acid substitutions against interferon-alpha receptor-2 binding sites using phage display system and evaluation of their biologic properties.
    Yamamoto K; Taniai M; Torigoe K; Yamamoto S; Arai N; Suemoto Y; Yoshida K; Okura T; Mori T; Fujioka N; Tanimoto T; Miyata M; Ariyasu H; Ushio C; Fujii M; Ariyasu T; Ikeda M; Ohta T; Kurimoto M; Fukuda S
    J Interferon Cytokine Res; 2009 Mar; 29(3):161-70. PubMed ID: 19196068
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Thermal stability of the WHO international standard of interferon alpha 2b (IFN-alpha 2b): application of new reporter gene assay for IFN-alpha 2b potency determinations.
    Caserman S; Menart V; Gaines Das R; Williams S; Meager A
    J Immunol Methods; 2007 Jan; 319(1-2):6-12. PubMed ID: 17196611
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Construction and expression of a novel bioactive IFN-alpha2b/CM4 fusion protein in Escherichia coli.
    Li NN; Liu P; Chen SJ; Lin QP; Zhou LF; Zhang SQ
    Microbiol Res; 2010 Feb; 165(2):116-21. PubMed ID: 19246180
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Pegylation and Cell Based Bioassay of Human Interferon-α2b Along its Docking Studies and Effect on Plasma Half-Life.
    Shahzadi SK; Qadir MA; Mahmood N; Ahmed M
    Protein Pept Lett; 2020; 27(3):219-224. PubMed ID: 31612813
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Characterization of the biological activities and physicochemical characteristics of recombinant bovine interferon-α₁₄.
    Shao J; Cao C; Bao J; Gao M; Wang J
    Mol Immunol; 2015 Mar; 64(1):163-9. PubMed ID: 25480392
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Response of hepatitis C genotype-4 naïve patients to 24 weeks of Peg-interferon-alpha2b/ribavirin or induction-dose interferon-alpha2b/ribavirin/amantadine: a non-randomized controlled study.
    El-Zayadi AR; Attia M; Barakat EM; Badran HM; Hamdy H; El-Tawil A; El-Nakeeb A; Selim O; Saied A
    Am J Gastroenterol; 2005 Nov; 100(11):2447-52. PubMed ID: 16279899
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Binding and biologic characterization of recombinant human serum albumin-eTGFBR2 fusion protein expressed in CHO cells.
    Wan A; Miao Y; Peng L; Cai Y; Chen Y; He Y; Yang J; Jin J; Li H
    Bioengineered; 2017 Sep; 8(5):600-612. PubMed ID: 28281868
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Efficient expression and purification of human interferon alpha2b in the methylotrophic yeast, Pichia pastoris.
    Shi L; Wang D; Chan W; Cheng L
    Protein Expr Purif; 2007 Aug; 54(2):220-6. PubMed ID: 17468009
    [TBL] [Abstract][Full Text] [Related]  

  • 58. WISH cell line: from the antiviral system to a novel reporter gene assay to test the potency of human IFN-α and IFN-β.
    Bürgi Mde L; Prieto C; Etcheverrigaray M; Kratje R; Oggero M; Bollati-Fogolín M
    J Immunol Methods; 2012 Jul; 381(1-2):70-4. PubMed ID: 22549076
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Highly glycosylated human alpha interferon: An insight into a new therapeutic candidate.
    Ceaglio N; Etcheverrigaray M; Conradt HS; Grammel N; Kratje R; Oggero M
    J Biotechnol; 2010 Mar; 146(1-2):74-83. PubMed ID: 20067809
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Field production and functional evaluation of chloroplast-derived interferon-alpha2b.
    Arlen PA; Falconer R; Cherukumilli S; Cole A; Cole AM; Oishi KK; Daniell H
    Plant Biotechnol J; 2007 Jul; 5(4):511-25. PubMed ID: 17490449
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.